[Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical antipsoriatic treatment].
There has been considerable variations between different authors in the evaluation of antipsoriatic therapies. Improvement homogeneity must be achieved in this field. The main specific methods have been investigated: inclusion criteria, assessment of disease progress and safety parameters in phase II and III clinical trials, evaluating antipsoriatic treatment.
Dahan
C
C
Centre de Pharmacologie Clinique Appliquée à la Dermatologie, (C.P.C.A.D.), Hôpital Pasteur, Nice.
Queille-Roussel
C
C
Verschoore
M
M
Schaefer
H
H
Revuz
J
J
De Prost
Y
Y
Guillaume
J C
JC
Ortonne
J P
JP
Czernielewski
J
J
D000287:Administration, Topical; D002986:Clinical Trials as Topic / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
Les essais cliniques en dermatologie. Evaluation de la tolérance et de l'efficacité d'un traitement topique antipsoriasique.